|Mr. Dennis P. Calvert||Chairman, Pres & CEO||320.3k||N/A||1963|
|Mr. Charles K. Dargan II, C.F.A.||Chief Financial Officer||N/A||N/A||1955|
|Mr. Joseph L. Provenzano||Exec. VP of Operations, Corp. Sec. & Director||186.56k||N/A||1969|
|Mr. Kenneth Reay Code||Chief Science Officer & Director||301.2k||N/A||1947|
|Dr. Tanya Rhodes Ph.D.||Chief Technology Officer of Clyra Medical Technologies||N/A||N/A||N/A|
|Mr. Steven V. Harrison II||Pres of Clyra Medical Technologies Inc||N/A||N/A||1959|
|Mr. Randall Moore||Pres of BioLargo Engineering, Science & Technologies||N/A||N/A||N/A|
|Dr. Richard Smith||Pres of BioLargo Water||N/A||N/A||N/A|
BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company's technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. It holds various issued patents, maintains a pipeline of products, and provides full-service environmental engineering services. The company's products include Advanced Oxidation system, a water treatment device that generates a series of oxidative species of iodine and other molecules; Aqueous Electrostatic Concentrator, a water treatment system that removes per- and polyfluoroalkyl substances from water; CupriDyne Clean industrial products, which reduce and eliminate tough odors and volatile organic compounds in various industrial settings; and Clyra advanced wound care products. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
BioLargo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.